Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats

International Journal of Neuropsychopharmacology

Volumn 9, Issue 1, 2006, Pages 51-61

  Yang, Yong ^a   Liu, Xing ^a   Long, Yan ^a   Wang, Fang ^a   Ding, Jian Hua ^a   Liu, Su Yi ^a   Sun, Ye Hong ^a   Yao, Hong Hong ^a   Wang, Hai ^b   Wu, Jie ^a,c   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Diazoxide; Iptakalim; Mitochondrial ATP sensitive potassium channels (mito KATP); Parkinson's disease; Rotenone

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DIAZOXIDE; DOPAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; IPTAKALIM; LEVODOPA; MESSENGER RNA; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; ROTENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; MALE; MITOCHONDRION; MOTOR PERFORMANCE; NEUROCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; BASAL GANGLIA; CATALEPSY; DECANOIC ACIDS; DIAZOXIDE; DISEASE MODELS, ANIMAL; DOPAMINE; HYDROXY ACIDS; LEVODOPA; MALE; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PARKINSONIAN DISORDERS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; ROTENONE; SUBSTANTIA NIGRA;

EID: 30344444268     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005547     Document Type: Article

References (56)

1. Abreu P, Llorente E, Sanchez JJ, Gonzalez MC (2000). Nitric oxide inhibits tyrosine hydroxylase of rat median eminence. Life Sciences 67, 1941-1946.
2. Alam M, Schmidt WJ (2002). Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behavioural Brain Research 136, 317-324.
3. Alam M, Schmidt WJ (2004). L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behavioural Brain Research 153, 439-446.
4. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H (1998). Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Proceedings of the National Academy of Sciences USA 95, 7659-7663.
5. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P (2001). Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. Journal of Biological Chemistry 276, 33369-33374.
6. Bashkatova V, Alam M, Vanin A, Schmidt WJ (2004). Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Experimental Neurology 186, 235-241.
7. Beckman JS, Carson M, Smith CD, Koppenol WH (1993). ALS, SOD and peroxynitrite. Nature 364, 584.
8. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature neuroscience 3, 1301-1306.
9. Blanchard-Fillion B, Souza JM, Friel T, Jiang GC, Vrana K, Sharov V, Barron L, Schoneich C, Quijano C, Alvarez B, Radi R, Przedborski S, Fernando GS, Horwitz J, Ischiropoulos H (2001). Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. Journal of Biological Chemistry 276, 46017-46023.
10. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 72, 248-254.
11. Brown GC, Bal-Price A (2003). Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Molecular Neurobiology 27, 325-355.
12. Brown GC, Borutaite V (2002). Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radical Biology and Medicine 33, 1440-1450.
13. Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, Horiguchi T (2004). Targeting mitochondrial ATP-sensitive potassium channels-a novel approach to neuroprotection. Brain Research Reviews 46, 282-294.
14. Dawson TM, Dawson VL (2002). Neuroprotective and Neurorestorative strategies for Parkinson's disease. Nature neuroscience 5, 1058-1061.
15. Dawson TM, Dawson VL (2003). Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
16. Ebadi M, Sharma SK (2003). Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxidants and Redox Signaling 5, 319-335.
17. Fahn S, Przedborski S (2000). Parkinsonism. In: Rowland, LP (Ed.), Merritt's Neurology (pp. 679-693). New York: Lippincott Williams & Wilkins.
18. Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997). Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Research 753, 157-162.
19. Fiskum G, Starkov A, Polster BM, Chinopoulos C (2003). Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Annals of the New York Academy of Sciences 991, 111-119.
20. Ghosh S, Standen NB, Galinanes M (2000). Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning. Cardiovascular Research 45, 934-940.
21. Greenamyre JT, MacKenzie GM, Peng TI, Stephans SE (1999). Mitochondrial dysfunction in Parkinson's disease. Biochemical Society Symposium 66, 85-97.
22. Gutman M, Singer TP, Beinert H, Casida JE (1970). Reaction sites of rotenone, piericidin A, and amytal in relation to the nonheme iron components of NADH dehydrogenase. Proceedings of the National Academy of Sciences USA 65, 763-770.
23. He Y, Imam SZ, Dong ZJ, Jankovic J, Ali SF, Appel SH, Le WD (2003). Role of nitric oxide in rotenone-induced nigro-striatal injury. Journal of Neurochemistry 86, 1338-1345.
24. Heneka MT, Feinstein DL (2001). Expression and function of inducible nitric oxide synthase in neurons. Journal of Neuroimmunology 114, 8-18.
25. Horgan DJ, Singer TP, Casida JE (1968). Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. 13. Binding sites of rotenone, piericidin A, and amytal in the respiratory chain. Journal Biological Chemistry 243, 834-843.
26. Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW (2003). Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 34, 1015-1020.
27. Hsieh PF, Chia L, Ni D, Cheng L, Ho Y, Tzeng S, Chang M, Hong J (2002). Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection. Neuroreport 13, 277-280.
28. + channel in the mitochondrial inner membrane. Nature 352, 244-247.
29. Ischiropoulos H, Duran D, Horwitz J (1995). Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. Journal of Neurochemistry 65, 2366-2372.
30. Johansson R, Pandita R, Poljakovic M, Garcia-Pascual A, Vente J, Persson K (2002). Activity and expression of nitric oxide synthase in the hypertrophied rat bladder and the effect of nitric oxide on bladder smooth muscle growth. The Journal of Urology 168, 2689-2694.
31. Kis B, Rajapakse NC, Snipes JA, Nagy K, Horiguchi T, Busija DW (2003). Diazoxide induces delayed preconditioning in cultured rat cortical neurons. Journal of Neurochemistry 87, 969-980.
32. Knowles RG, Moncada S (1994). Nitric oxide synthase in mammals. Biochemical Journal 298, 249-258.
33. Liss B, Roeper J (2001). ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News in Physiological Sciences 16, 214-217.
34. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP (2002). Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. Journal of Cerebral Blood Flow and Metabolism 22, 431-443.
35. Mattson M., Liu D (2003). Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochemical and Biophysical Research Communications 304, 539-549.
36. Meissner W, Hill MP, Tison F, Gross CE, Bezard E (2004). Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends in Pharmacological Sciences 25, 249-253.
37. Rajapakse N, Shimizu K, Kis B, Snipes J, Lacza Z, Busija D (2002). Activation of mitochondrial ATP-sensitive potassium channels prevents neuronal cell death after ischemia in neonatal rats. Neuroscience Letters 327, 208-212.
38. Sato T, Sasaki N, Seharaseyon J, O'Rourke B, Marban E (2000). Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. Circulation 101, 2418-2423.
39. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000). CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777-787.
40. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990). Mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurochemistry 54, 823-827.
41. Schapira AH, Gu M, Taanman JW, Tabrizi SJ, Seaton T, Cleeter M, and Cooper JM (1998). Mitochondria in the etiology and pathogenesis of Parkinson's disease. Annals of Neurology 44, S89-S98.
42. Sherer TB, Kim JH, Betarbet R, Greenamyre JT (2003). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Experimental Neurology 179, 9-16.
43. Sparrow JR (1994-1995). Inducible nitric oxide synthase in the central nervous system. Journal of Molecular Neuroscience 5, 219-229.
44. Steece-Collier K, Maries E, Kordower JH (2002). Etiology of Parkinson's disease: Genetics and environment revisited. Proceedings of the National Academy of Sciences USA 99, 13972-13974.
45. +P channels in mitochondria. Biochemical and Biophysical Research Communications 241, 693-697.
46. Tai KK, McCrossan ZA, Abbott GW (2003). Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. Journal of Neurochemistry 84, 1193-1200.
47. Teshima Y, Akao M, Baumgartner WA, Marban E (2003). Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels. Brain Research 990, 45-50.
48. Thiffault C, Langstone JW, Di Monte DA (2000). Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Research 885, 283-288.
49. Vincent SR, Kimura H (1992). Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
50. Wang H (1998). ATP-sensitive potassium channel as a new target for development of antihypertensive drugs. Acta Pharmacologica Sinica 19, 257-276.
51. Wang H (2003). Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms. Drug Development Research 58, 65-68.
52. Wang H, Zhang YL, Tang XC, Feng HS, Hu G (2004). Targeting ischaemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Molecular Pharmacology 66, 1-9.
53. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N (2001). Protective role of ATP sensitive potassium channels in hypoxia-induced generalized seizure. Science 292, 1543-1546.
54. Yang Y, Liu X, Ding JH, Sun J, Long Y, Wang F, Yao HH, Hu G (2004). Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells. Neuroscience Letters 366, 53-57.
55. Zhang Y, Dawson VL, Dawson TM (2000). Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease 7, 240-250.
56. Zhu DY, Deng Q, Yao HH, Wang DC, Deng Y, Liu GQ (2002). Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient focal cerebral ischemia in mice. Life Sciences 71, 1985-1996.